banner
 
bar

program

slides

  test

syllabus
bar
 
 

New Perspectives in Sepsis
for the Critical Care Nurse

Webcast CME Disclosure

Please read this notice and click the acknowledgement
at the bottom of the page to continue.

Program Medium:

Internet-based program

Method of Physician Participation Utilized in Learning Process:

There are no fees for participating and receiving CME credit for this activity. During the period June 18, 2010 through June 18, 2012 participants must 1) read the learning objectives and faculty disclosures; 2) study the educational activity; 3) register and complete the evaluation form; and 4) print out your CME certificate.

Estimated Time to Complete Educational Activity:

1.0 hour

Course Overview:

In this web-based program, participants will learn how recent advances in basic and clinical research have helped to advance the understanding of treatment advances in the management of sepis.

Release Date:

June 18, 2010

Expiration Date:

June 18, 2012

Intended Audience:

This activity has been designed to meet the educational needs of all critical care physicians and nurses, emergency medicine specialists, nurses, pharmacists, respiratory therapists and other involved in the care of critically ill patients in the intensive care or emergency medicine setting

Registration:

Enrollment for this WebCAST is complimentary, and clinicians are invited to participate in this CME-certified WebCAST and/or share this invitation with other colleagues, departmental staff members, and healthcare professionals.

Grantor Support:

Teva NeuroscienceSupported by an independent
educational grant from
Eisai, Inc.

Accreditation Statement:

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of University of Massachusetts Medical School and CMEducation Resources, LLC. University of Massachusetts Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement:

University of Massachusetts Medical School designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s). Physicians should only claim credit commensurate with the extent of their participation in the activity.

Policy on Faculty & Provider Disclosure:

It is the policy of University of Massachusetts Medical School to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by University of Massachusetts Medical School are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships with those supporting the activity or others whose products or services are discussed. Faculty disclosure will be provided in the activity materials.

Program Faculty and Disclosures:

Ruth M. Kleinpell, PhD, RN-CS, FAAN, FAANP, FCCM
Director of the Center for Clinical
Research and Scholarship
Rush University Medical Center
Professor, Rush University College of Nursing
Chicago, IL

Nothing to disclose

Steven Opal, MD
Chairman Elect, International Sepsis Forum
Professor of Medicine at Brown Medical School
Director of the Infectious Disease Division
Memorial Hospital of Rhode Island
Pawtucket, RI

Research Support: Inimex, Sirtris, Eisai, Atoxbio

Phillip Dellinger, MD
Professor of Medicine
Robert Wood Johnson Medical School
Director of the Critical Care Section
Cooper Health System
Camden, NJ

Advisor: B-R-A-H-M-S.
Research Activities: AstraZeneca, B-R-A-H-M-S, Artisan
Speakers Bureau: Eli Lilly.
Consultant: Hutchinson Technologies

Program Managers and Web Editor Disclosure:

Program Manager Gideon Bosker, MD has nothing to disclose.

Program Reviewers Denise Leary and Richard Aghababian, MD have nothing to disclose.

Educational Objectives:

Participants will be able to:

  • Describe the prognostic factors that determine clinical outcomes of patient with severe sepsis
  • Describe the epidemiology and causative factors of sepsis
  • Identify the potential pathophysiological and clinical impact of modulating TLR-derived signals in order to mitigate adverse effects of immune responses observed in septic shock syndrome
  • Discuss emerging strategies for improving patient care and clinical outcomes for severe sepsis syndrome
  • Analyze evolving strategies for improving outcomes in sepsis that are focused on suitable targets for interrupting the inflammatory cascade

Hardware and Software Requirements:

To participate in this program, viewers must have a PC or Macintosh computer that has active, ongoing internet access for the duration of the program, as well as a compatible Flash-viewer. An email address is required for registration, and a printer is required to printout the CME certificate.

Privacy Policy

When you participate in a CME activity offered by CMEducation Resources, we ask you for your name, degree, affiliation, street address, telephone number, fax number, and/or e-mail address (the "Information"). We use that Information in the following ways:

  • We use the Information to grade your post-test and to send you a certificate of completion of the CME activity. If we use a third-party company to grade your post-test and issue certificates of completion, we will give the Information to that company for that purpose only.
  • For each CME activity that you take, you must complete an evaluation questionnaire. That questionnaire asks if you are willing to participate in a follow-up survey. If you answer yes, we will use your name and contact information to send you the survey.
  • We may use the Information to send you information about other CME activities that CMEducation Resources is offering.
  • If our company is acquired by or merged into another company, we may make the Information available to the new owner/entity to use in the ways described above, to enable it to continue our business.
  • You should check this privacy policy periodically to see whether we have made any changes.

Disclaimer:

Copyright © 2011 Resources, LLC All rights reserved.

Reproduction, distribution, or translation without express written permission is strictly prohibited.

Content on this webcast reflects the opinions, output, and analyses of experts, investigators, educators, and clinicians whose activities for, while independent, are commercially supported by the sponsor noted at the start of each activity.

Content on this webcast is not meant to be, nor substitute for national guidelines or recommendations generated by professional, academic societies, colleges, or associations.

Content on this webcast is intended for educational value only. Its contents, analyses, and any recommendation made herein are intended to make scientific information and opinion available to health professionals, to stimulate thought, and further investigation. This webcast is not designed nor is any aspect of the contents here intended to provide advice regarding medical diagnosis or treatment for any individual case. Any decisions regarding diagnosis and/or management of any individual patient or group of patients should be made on individual basis after having consulted appropriate sources, whether they be appropriate consultants and/or guidelines and recommendations issued by national organizations, professional societies, governmental health organizations, or similar bodies. This webcast is not intended for use by the layman.

Opinions expressed herein are not necessarily those of CMEducation Resources, LLC, program supporters or accreditors, but reflect the opinions and analyses of the experts who have authored the material. Mention of products or services does not constitute endorsement. Clinical, legal, financial, and other comments are offered for general guidance only; and professional counsel should be sought for all specific situations.

bar

program

slides

  test

syllabus
bar

I have read this CME information statement and wish to participate in this CME activity.

Copyright © 2011 Resources, LLC All rights reserved.

 
6

 

Key Program Topics Include:

ACCESS Trial
antibiotics
APACHE II
Apoptosis
Biglycans
E5564
Endotoxemia
Talactoferrin

Endotoxin in Critically Ill
Epitopes
Eritoran
Fibronectin
HMGB1
Hyaluronan
hypotension
Immune Modulation

 

immunosuppression
Inflammatory Cascade
IRAK-4
LPS
lymphocytes
Multicentric, randomized, double-blind trial
Polymyxin B
Sepsis
Serum lactate
Signalsome
TAK-242
TLR
Pyogenic
TLR4 Ligands
Toll like receptor
Toll-like receptor